Os03g0405900 Antibody

Shipped with Ice Packs
In Stock

Description

Biological Significance of Os03g0405900

The Os03g0405900 gene encodes a probable nucleoredoxin 1-2, a redox-regulating protein involved in maintaining cellular oxidative balance. Nucleoredoxins are crucial for mitigating oxidative stress during phosphorus (P) deprivation, a common abiotic stress in plants. Under low P conditions, rice roots upregulate nucleoredoxins to protect cellular components from reactive oxygen species (ROS) while enhancing phosphate uptake efficiency .

Key features:

  • Molecular weight: Predicted ~22 kDa (exact weight depends on post-translational modifications) .

  • Functional domains: Contains a thioredoxin-like fold critical for redox activity .

Research Applications of Os03g0405900 Antibody

This antibody is primarily utilized in proteomic and molecular studies to:

  • Detect nucleoredoxin expression in rice tissues under varying phosphorus conditions .

  • Quantify protein levels via Western Blot (WB) and ELISA .

  • Localize nucleoredoxin in root cells using immunohistochemistry .

Table 1: Key Performance Metrics in Phosphorus Stress Studies6

Protein IDDescriptionFold Change (RLP/RCK)p Value
Os03g0405900Probable nucleoredoxin 1-22.220.0006

RLP/RCK: Ratio of root tissue under low phosphorus (RLP) vs. control (RCK).

Validation and Characterization

Antibody specificity for Os03g0405900 is validated using:

  • Knockout (KO) cell lines to confirm target binding .

  • Immunoprecipitation (IP) followed by mass spectrometry to verify protein identity .

  • Cross-reactivity tests against homologous proteins (e.g., nucleoredoxin 1-1, Os03g0405500) .

Recent studies highlight that ~50–75% of commercial antibodies for plant proteins lack sufficient validation, emphasizing the need for rigorous testing . For example, YCharOS initiatives demonstrated that recombinant antibodies outperform polyclonal and monoclonal variants in specificity .

Phosphorus Stress Response

Os03g0405900 is upregulated 2.2-fold under phosphorus-deficient conditions, correlating with enhanced ROS scavenging and improved root architecture . Its expression is co-regulated with phosphate transporters (e.g., PHT1-8) and phosphatases .

Interaction Networks

Nucleoredoxin 1-2 interacts with:

  • Thioredoxin H1 (TRXH) to regulate redox signaling .

  • Glycosyl hydrolases involved in cell wall remodeling during nutrient stress .

Challenges and Future Directions

  • Antibody reliability: Only 20–40% of commercially available antibodies for plant proteins are validated for specific applications .

  • Scalability: High-throughput validation pipelines (e.g., YCharOS) are needed to improve reagent reproducibility .

  • Therapeutic potential: While primarily used in research, plant-derived antibodies like Os03g0405900 could inspire bioengineered crops with stress resilience .

Technical Protocols

Recommended dilutions :

  • Western Blot: 1:200–1:1000.

  • Immunoprecipitation: 0.5–4.0 µg per 1–3 mg lysate.

Controls: Use rabbit IgG isotype controls (e.g., Proteintech 30000-0-AP) to minimize false positives .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Os03g0405900 antibody; LOC_Os03g29240 antibody; OsJ_11208 antibody; OSJNBa0002D18.22 antibody; OSJNBb0074M06.3 antibody; Probable nucleoredoxin 1-2 antibody; OsNrx1-2 antibody; EC 1.8.1.8 antibody
Target Names
Os03g0405900
Uniprot No.

Target Background

Function
This antibody targets a probable thiol-disulfide oxidoreductase, which may play a role in various redox reactions.
Database Links

KEGG: osa:4333077

STRING: 39947.LOC_Os03g29240.1

UniGene: Os.6150

Protein Families
Nucleoredoxin family

Q&A

What is Os03g0405900 and why is it significant for antibody-based research?

Os03g0405900 (MSU ID: LOC_Os03g29240) encodes a probable nucleoredoxin 1-2 protein in rice (Oryza sativa). This protein has shown significant upregulation (ratio of 2.22151414, p-value 0.0006) under phosphorus deficiency conditions, making it an important marker for phosphorus stress response . Nucleoredoxins are thioredoxin-related proteins involved in redox regulation and signaling pathways. The protein's association with the quantitative trait locus (QTL) qTDW-2 indicates its potential role in phosphorus use efficiency and stress adaptation mechanisms . Antibodies targeting Os03g0405900 are valuable tools for investigating phosphorus deficiency responses and redox signaling networks in plants.

How does Os03g0405900 expression compare to related nucleoredoxin genes under phosphorus stress?

Proteomic analysis reveals that Os03g0405900 (Probable nucleoredoxin 1-2) shows a 2.22-fold upregulation (p=0.0006) under low phosphorus conditions, while its related family member Os03g0405500 (Probable nucleoredoxin 1-1) shows a 1.82-fold increase (p=0.017644) . This differential expression pattern suggests distinct functional roles for these nucleoredoxin variants in phosphorus stress response. The table below highlights the comparison:

RAP (Os ID)MSU (LOC_Os ID)DescriptionRatio (RLP/RCK)p Value
Os03g0405900LOC_Os03g29240Probable nucleoredoxin 1-22.221514140.0006
Os03g0405500LOC_Os03g29190Probable nucleoredoxin 1-11.8223775140.017644

When developing antibodies against either variant, researchers should carefully consider epitope selection to ensure specificity between these closely related proteins.

What experimental techniques are most appropriate for Os03g0405900 protein detection?

For effective Os03g0405900 protein detection, several techniques can be employed depending on research objectives:

  • Western blotting: Optimal for quantitative analysis of protein expression levels across different treatments or tissues. Use 10-12% SDS-PAGE gels with reducing conditions. Transfer to PVDF membranes typically yields better results than nitrocellulose for plant proteins.

  • Immunoprecipitation: Valuable for studying protein-protein interactions. Cross-linking with formaldehyde before extraction can preserve transient interactions.

  • Immunohistochemistry/Immunofluorescence: For localizing Os03g0405900 within specific tissues or cellular compartments. Fixation with 4% paraformaldehyde is generally effective for plant tissues.

  • ELISA: Suitable for high-throughput quantitative analysis across multiple samples. Consider using a sandwich ELISA approach with a capture antibody against Os03g0405900 and a detection antibody against a fusion tag if using recombinant proteins.

Similar to p40 antibody methodology, validation should include positive controls using tissues known to express the target protein and negative controls with tissues where expression is absent or knockdown models .

How can researchers develop specific antibodies against Os03g0405900 while avoiding cross-reactivity with Os03g0405500?

Developing highly specific antibodies against Os03g0405900 (nucleoredoxin 1-2) requires careful epitope selection to differentiate it from the closely related Os03g0405500 (nucleoredoxin 1-1). The following methodological approach is recommended:

  • Sequence alignment analysis: Identify unique regions in Os03g0405900 that differ from Os03g0405500. Focus on hydrophilic, surface-exposed regions that are likely accessible to antibodies.

  • Epitope selection criteria:

    • Choose peptide sequences 12-20 amino acids in length

    • Select regions with <60% sequence identity to Os03g0405500

    • Avoid transmembrane domains and signal peptides

    • Prioritize regions with high antigenicity scores

  • Validation strategy:

    • Test against recombinant Os03g0405900 and Os03g0405500 proteins

    • Perform competitive binding assays with the immunizing peptide

    • Include knockout/knockdown tissues as negative controls

    • Conduct Western blots with tissues expressing different levels of both proteins

    • Employ immunoprecipitation followed by mass spectrometry to confirm specificity

Similar to the approach used with p40 antibody development, where epitope selection focused on unique regions not shared with p63, specificity testing should be rigorous to ensure the antibody recognizes only the intended target .

What are the optimal immunoprecipitation protocols for studying Os03g0405900 protein interactions under phosphorus stress conditions?

For studying Os03g0405900 protein interactions under phosphorus stress conditions, consider the following optimized immunoprecipitation protocol:

  • Plant material preparation:

    • Grow rice plants under normal and low phosphorus conditions (as in the referenced study where RLP/RCK ratio was 2.22)

    • Harvest tissues at multiple time points to capture dynamic interactions

    • Flash freeze samples in liquid nitrogen

  • Extraction buffer optimization:

    • Base buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.1% Triton X-100

    • Include phosphatase inhibitors (10 mM NaF, 1 mM Na₃VO₄, 5 mM β-glycerophosphate)

    • Add protease inhibitor cocktail

    • Consider including 10 mM DTT to maintain redox-sensitive interactions

    • For crosslinking studies, use 1% formaldehyde in PBS for 10 minutes

  • Immunoprecipitation procedure:

    • Pre-clear lysate with Protein A/G beads

    • Incubate with Os03g0405900 antibody (5-10 μg) overnight at 4°C

    • Add pre-washed Protein A/G beads for 2-3 hours

    • Wash extensively (at least 5 times) with decreasing salt concentrations

    • Elute with 2X SDS sample buffer or acidic glycine buffer

  • Controls and validation:

    • Include IgG control immunoprecipitations

    • Use tissues with different Os03g0405900 expression levels (e.g., normal vs. P-deficient)

    • Consider reverse immunoprecipitation with antibodies against suspected interacting partners

    • Validate interactions using alternative methods (yeast two-hybrid, BiFC)

  • Analysis of immunoprecipitated complexes:

    • Western blot for known/suspected partners

    • Mass spectrometry for unbiased identification of all interacting proteins

    • Compare interactome under normal vs. low phosphorus conditions

How can researchers integrate antibody-based detection with transcriptomic data for comprehensive Os03g0405900 functional analysis?

Integrating antibody-based detection with transcriptomic data enables robust functional analysis of Os03g0405900. The following methodological framework is recommended:

  • Correlation analysis workflow:

    • Establish timeline experiments where both protein and RNA are extracted from the same samples

    • Quantify Os03g0405900 protein levels via Western blot or ELISA

    • Measure Os03g0405900 mRNA expression via qRT-PCR or RNA-seq

    • Calculate Pearson or Spearman correlation coefficients between protein and mRNA levels

    • Create time-lag correlation analyses to detect delayed protein expression

  • Multi-omics integration approach:

    • Create overlapping datasets using consistent experimental conditions

    • Normalize protein expression data (from antibody-based assays) and transcript data

    • Apply statistical methods like ANOVA or mixed linear models to identify consistent patterns

    • Consider using multivariate analysis methods (PCA, PLS-DA) to identify co-regulated genes/proteins

  • Discrepancy analysis:

    • Identify conditions where transcript and protein levels show discordance

    • Investigate potential post-transcriptional regulation mechanisms

    • Examine protein stability using cycloheximide chase assays and the Os03g0405900 antibody

    • Analyze phosphorylation or other post-translational modifications that may affect protein stability

  • Pathway analysis enhancement:

    • Use antibody-based co-immunoprecipitation to identify protein interaction networks

    • Compare interaction networks with co-expression networks from transcriptomic data

    • Identify regulatory hubs that may affect both transcript and protein levels

In the referenced phosphorus stress study, integrating the proteomic data showing 2.22-fold protein upregulation with transcriptomic data provided complementary insights into the role of Os03g0405900 in stress response mechanisms .

What controls should be included when validating a new Os03g0405900 antibody for specificity?

Validating a new Os03g0405900 antibody requires a comprehensive set of controls to ensure specificity and reliability:

  • Essential positive controls:

    • Recombinant Os03g0405900 protein (full-length or fragment)

    • Phosphorus-stressed rice tissues known to upregulate Os03g0405900 (ratio of 2.22 as reported)

    • Transgenic plants overexpressing Os03g0405900 with an epitope tag

  • Critical negative controls:

    • Os03g0405900 knockout/knockdown plants

    • Pre-immune serum at equivalent concentration

    • Competitive inhibition with immunizing peptide

    • Non-expressing tissues or species

    • Secondary antibody only

  • Specificity controls:

    • Recombinant Os03g0405500 (nucleoredoxin 1-1) to test for cross-reactivity

    • Other related thioredoxin family proteins

    • Tissues from plants expressing varying levels of Os03g0405900

  • Application-specific controls:

    • For Western blotting: Molecular weight markers, loading controls

    • For immunoprecipitation: IgG control, input sample

    • For immunohistochemistry: Peptide competition, isotype control

    • For ELISA: Standard curve with recombinant protein

  • Technical validation:

    • Multiple antibody concentrations/dilutions

    • Different detection methods (fluorescent vs. chromogenic)

    • Batch testing to ensure reproducibility

This approach parallels the rigorous validation used in p40 antibody development, where specificity testing against potential cross-reactive proteins was crucial for reliable results .

How can researchers troubleshoot weak or inconsistent signals when using Os03g0405900 antibodies in Western blotting?

When encountering weak or inconsistent signals with Os03g0405900 antibodies in Western blotting, follow this systematic troubleshooting approach:

  • Sample preparation optimization:

    • Buffer composition: Try different extraction buffers containing various detergents (RIPA, NP-40, Triton X-100)

    • Protease inhibitors: Ensure complete protease inhibitor cocktail is fresh and active

    • Reducing agents: Test different concentrations of β-mercaptoethanol or DTT (5-100 mM)

    • Sample denaturation: Vary heating time (5-10 minutes) and temperature (70-100°C)

    • Protein concentration: Load increasing amounts (10-100 μg) to determine optimal loading

  • Electrophoresis and transfer parameters:

    • Gel percentage: Optimize acrylamide percentage based on protein size

    • Transfer conditions: Test wet transfer vs. semi-dry, vary buffer composition and time

    • Membrane selection: Compare PVDF and nitrocellulose membranes

    • Transfer efficiency: Verify with reversible protein stains (Ponceau S)

  • Antibody optimization:

    • Concentration: Test serial dilutions (1:500 to 1:10,000)

    • Incubation conditions: Vary temperature (4°C, room temperature) and time (1 hour to overnight)

    • Blocking agents: Compare different blockers (5% milk, 5% BSA, commercial blockers)

    • Secondary antibody: Optimize dilution and consider enzyme-conjugated vs. fluorescent detection

  • Signal enhancement strategies:

    • Extended exposure times

    • More sensitive substrates for HRP (Super Signal West Femto vs. ECL)

    • Signal amplification systems (biotin-streptavidin)

    • Concentration of protein by immunoprecipitation before Western blotting

  • Consider biological variables:

    • Developmental stage: Os03g0405900 expression varies with plant development

    • Stress conditions: Ensure phosphorus deficiency is sufficient to induce upregulation

    • Tissue selection: Choose tissues known to express Os03g0405900

If persistent problems occur, consider epitope retrieval techniques or alternative antibodies targeting different epitopes of Os03g0405900.

What considerations should be made when designing immunolocalization studies for Os03g0405900 in plant tissues?

Designing effective immunolocalization studies for Os03g0405900 requires careful consideration of several methodological aspects:

  • Tissue preparation protocols:

    • Fixation: Compare 4% paraformaldehyde, glutaraldehyde, or combination fixatives

    • Embedding media: Paraffin for light microscopy vs. resin for higher resolution

    • Section thickness: Optimize between 5-10 μm for immunofluorescence, 70-100 nm for immunogold

    • Antigen retrieval: Test heat-induced (citrate buffer) and enzymatic methods

    • Tissue permeabilization: Optimize detergent concentration (0.1-0.5% Triton X-100) and time

  • Antibody application strategy:

    • Primary antibody dilution: Start with 1:100-1:500 and adjust as needed

    • Incubation parameters: Compare 1-2 hours at room temperature vs. overnight at 4°C

    • Washing protocol: Determine optimal buffer composition and washing times

    • Secondary antibody selection: Choose fluorophores appropriate for tissue autofluorescence

    • Signal amplification: Consider tyramide signal amplification for low-abundance proteins

  • Essential controls:

    • Omission of primary antibody

    • Pre-absorption with immunizing peptide

    • Comparison with Os03g0405900 gene expression patterns

    • Phosphorus-sufficient vs. phosphorus-deficient tissues (expecting 2.22-fold difference)

    • Co-localization with known compartment markers

  • Technical considerations:

    • Counter-staining: DAPI for nuclei, cell wall stains for structural context

    • Mounting media: Anti-fade reagents to prevent photobleaching

    • Microscope settings: Consistent exposure times and gain settings

    • Z-stack acquisition: For 3D reconstruction of protein localization

    • Quantification methods: Fluorescence intensity measurement protocols

  • Biological considerations:

    • Developmental stages: Compare tissues at different developmental points

    • Stress progression: Examine localization changes during onset and prolonged P deficiency

    • Diurnal changes: Consider potential temporal variation in protein localization

When optimizing these protocols, begin with tissues known to express high levels of Os03g0405900, such as tissues under phosphorus stress conditions as identified in the proteomic study .

How should researchers quantify and analyze Western blot data for Os03g0405900 under various phosphorus conditions?

For rigorous quantification and analysis of Western blot data for Os03g0405900 under varying phosphorus conditions, implement the following methodological approach:

  • Experimental design for quantitative Western blotting:

    • Include a concentration gradient of recombinant Os03g0405900 to create a standard curve

    • Process all experimental samples simultaneously to minimize technical variation

    • Include at least 3-4 biological replicates per condition

    • Load equal amounts of total protein (verified by protein assay)

    • Include multiple loading controls (actin, GAPDH, and total protein stain)

  • Image acquisition protocol:

    • Capture images within the linear dynamic range of the detection system

    • Use identical exposure settings for all experimental samples

    • Include oversaturation alerts during image acquisition

    • For fluorescent detection, capture multiple channels simultaneously

  • Quantification methodology:

    • Use software that supports background subtraction (ImageJ, Image Lab, etc.)

    • Define measurement regions consistently across all samples

    • Normalize Os03g0405900 signal to loading controls

    • Calculate relative fold changes compared to control conditions

    • For absolute quantification, use the recombinant protein standard curve

  • Statistical analysis:

    • Test for normal distribution of data (Shapiro-Wilk test)

    • Apply appropriate statistical tests (t-test for two conditions, ANOVA for multiple conditions)

    • Use post-hoc tests (Tukey's HSD) for pairwise comparisons

    • Report p-values and confidence intervals

    • Consider regression analysis for time-course or dose-response experiments

  • Data presentation:

    • Present quantification with error bars representing standard deviation or SEM

    • Include representative blot images

    • Indicate statistical significance levels

    • Create correlation plots between protein levels and relevant physiological parameters

When interpreting results, compare observed fold changes with the 2.22-fold upregulation (p=0.0006) reported in the proteomic study as a reference point for validation.

How should researchers interpret contradictory results between antibody-based protein detection and mRNA expression data for Os03g0405900?

When faced with discrepancies between antibody-based protein detection and mRNA expression data for Os03g0405900, adopt the following systematic interpretation framework:

  • Validation of both methodologies:

    • Confirm antibody specificity through Western blot with recombinant protein and knockout controls

    • Verify PCR primer specificity through sequencing of amplification products

    • Check for technical issues in both protein and RNA extraction protocols

    • Include positive controls for both techniques

  • Biological explanations for discrepancies:

    • Temporal delay: Transcription often precedes protein accumulation (6-8 hour lag typically)

    • Post-transcriptional regulation: miRNAs may inhibit translation without affecting mRNA levels

    • Protein stability: Differences in protein turnover rates affecting steady-state levels

    • Translational efficiency: Codon bias or secondary structures in mRNA affecting translation rate

    • Post-translational modifications: Changes affecting antibody recognition without altering protein abundance

  • Analytical approach to resolve contradictions:

    • Time-course experiments to detect temporal shifts between mRNA and protein peaks

    • Polysome profiling to assess translational efficiency of Os03g0405900 mRNA

    • Protein stability assays using cycloheximide or pulse-chase experiments

    • Analysis of phosphorylation status or other post-translational modifications

    • Subcellular fractionation to check for compartmentalization changes

  • Integration strategies:

    • Create a combined scoring system weighting both protein and mRNA data

    • Consider pathway-level analysis rather than focusing solely on Os03g0405900

    • Examine related proteins (e.g., Os03g0405500, nucleoredoxin 1-1) for similar patterns

    • Apply mathematical modeling to predict expected protein levels from mRNA data

  • Reporting recommendations:

    • Present both datasets with clear acknowledgment of discrepancies

    • Provide multiple working hypotheses to explain contradictions

    • Suggest follow-up experiments to resolve conflicts

    • Consider the biological significance of the discrepancy itself as a finding

Differential regulation between transcript and protein levels may have functional significance in stress response mechanisms, as observed in various phosphorus-responsive proteins .

What methodologies are appropriate for comparing Os03g0405900 antibody specificity across different experimental conditions?

For rigorous comparison of Os03g0405900 antibody specificity across different experimental conditions, implement the following methodological framework:

  • Cross-platform validation strategy:

    • Compare multiple detection methods (Western blot, ELISA, immunoprecipitation)

    • Test antibody performance in native vs. denaturing conditions

    • Evaluate antibody in both reducing and non-reducing environments

    • Assess epitope accessibility in fixed vs. fresh tissues

  • Antibody performance metrics:

    • Signal-to-noise ratio calculation under each condition

    • Limit of detection determination using purified protein standards

    • Dynamic range assessment using dilution series

    • Coefficient of variation across technical and biological replicates

    • Cross-reactivity profile with related proteins (especially Os03g0405500)

  • Experimental validation designs:

    • Peptide competition assays under each condition

    • Knockout/knockdown validation across all experimental setups

    • Epitope-tagged recombinant protein expression as positive control

    • Immunodepletion studies to confirm specificity

    • Mass spectrometry validation of immunoprecipitated proteins

  • Comparative analysis between conditions:

    • Create a scoring matrix evaluating antibody performance across parameters

    • Use statistical approaches (ANOVA) to identify significant differences

    • Generate ROC curves to assess diagnostic value under each condition

    • Calculate specificity and sensitivity metrics for each experimental setup

  • Standard operating procedure development:

    • Document optimal conditions for each application

    • Create decision trees for troubleshooting

    • Establish quality control thresholds for acceptable performance

    • Develop standard curves for quantitative applications

This approach parallels the rigorous validation methodology used for diagnostic antibodies like p40 , where specificity was systematically tested against potential cross-reactive proteins across multiple sample types and detection methods.

How can Os03g0405900 antibodies be utilized to investigate its role in the phosphorus stress response pathway?

Os03g0405900 antibodies can be strategically employed to investigate this protein's role in phosphorus stress response through the following methodological approaches:

  • Temporal and spatial expression profiling:

    • Time-course analysis following phosphorus deprivation (hours to days)

    • Tissue-specific accumulation patterns using immunohistochemistry

    • Subcellular localization changes under stress using immunofluorescence

    • Quantitative Western blot analysis across diverse rice cultivars with varying P-efficiency

  • Protein interaction network mapping:

    • Co-immunoprecipitation followed by mass spectrometry to identify interacting partners

    • Proximity labeling (BioID) using Os03g0405900 fusion proteins

    • Yeast two-hybrid validation of potential interactions

    • In situ protein-protein interaction studies using BiFC or FRET

    • Comparative interactome analysis between normal and P-deficient conditions

  • Post-translational modification analysis:

    • Phosphorylation state monitoring using phospho-specific antibodies

    • Redox state analysis using redox proteomics approaches

    • Ubiquitination patterns using co-immunoprecipitation with ubiquitin antibodies

    • Stability assessment using cycloheximide chase assays

  • Functional studies:

    • Antibody-mediated inhibition in cellular extracts or permeabilized cells

    • Immunodepletion studies to assess enzymatic activity contributions

    • Correlation of protein levels with physiological parameters of P-efficiency

    • Analysis of protein-DNA interactions using ChIP if DNA-binding activity is suspected

  • Integration with QTL analysis:

    • Protein expression quantification in populations segregating for qTDW-2 QTL

    • Correlation of protein levels with phenotypic variation in P-efficiency traits

    • Development of protein-based markers for selection in breeding programs

The proteomic data showing significant upregulation (2.22-fold, p=0.0006) under phosphorus stress conditions provides a strong foundation for these investigations, particularly when combined with the protein's genetic association with the qTDW-2 QTL relevant to phosphorus use efficiency .

What emerging technologies might enhance the application of antibodies for studying Os03g0405900?

Emerging technologies offer promising opportunities to enhance antibody-based studies of Os03g0405900, particularly in understanding its role in phosphorus stress response:

  • Advanced imaging technologies:

    • Super-resolution microscopy (PALM, STED, SIM) for nanoscale localization

    • Expansion microscopy for enhanced spatial resolution in plant tissues

    • Light-sheet microscopy for rapid 3D imaging with minimal photodamage

    • Correlative light and electron microscopy (CLEM) for ultrastructural context

    • Label-free imaging methods to complement antibody-based detection

  • Single-cell and spatial technologies:

    • Single-cell proteomics to detect cell-type specific responses

    • Spatial transcriptomics combined with in situ antibody detection

    • Mass cytometry (CyTOF) for multiparameter protein profiling

    • Imaging mass spectrometry for spatial protein distribution

    • Digital spatial profiling for quantitative in situ protein measurement

  • Protein dynamics tools:

    • FRAP (Fluorescence Recovery After Photobleaching) for protein mobility studies

    • Optogenetic tools combined with antibody detection

    • Microfluidic approaches for real-time monitoring of protein responses

    • Live-cell imaging with nanobodies derived from conventional antibodies

    • CRISPR-mediated tagging for endogenous protein tracking

  • High-throughput antibody applications:

    • Microwestern arrays for parallel analysis of multiple conditions

    • Reverse phase protein arrays for large-scale screening

    • Antibody arrays for studying multiple phosphorus-responsive proteins simultaneously

    • Automated immunoprecipitation platforms for standardized interaction studies

    • Multiplex imaging with antibody barcoding techniques

  • Computational integration approaches:

    • Machine learning algorithms for antibody binding prediction

    • Network analysis tools for interpreting protein interaction data

    • Multi-omics data integration platforms

    • Structural modeling to predict antibody epitope accessibility

    • Systems biology approaches to position Os03g0405900 in stress response networks

Implementation of these technologies could significantly enhance our understanding of Os03g0405900's role in phosphorus stress response, particularly in relation to the 2.22-fold upregulation observed in proteomic studies and its association with the qTDW-2 QTL .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.